Viewing nowLipidel NT Tablet (Fenofibrate)
Fenofibrate 145mg
Tablet · Prescription medication
Abbott Korea Co., Ltd.

MFDS item code 202202576 · Approved 2022.06.21 · Insurance code 644206570
Improvement of primary hyperlipidemia (hypercholesterolemia, hypertriglyceridemia)
This medication is used for several types of dyslipidemia, including primary hyperlipidemia, which encompasses combined hypercholesterolemia and hypertriglyceridemia. It helps effectively control blood cholesterol and triglyceride levels, thereby reducing the risk of cardiovascular diseases. Thus, it plays an important role in the treatment of hyperlipidemia.
As fenofibrate, take 145 mg orally once daily, regardless of meals, while strictly adhering to dietary modifications. This medication may be absorbed less efficiently on an empty stomach; therefore, take it immediately after meals (except for the 145 mg formulation).
There is currently no clinical data regarding the use of this medication in pediatric patients.
This medication should not be used in patients with poor liver function, as it can be harmful if the liver is damaged. Patients with moderate to severe kidney impairment should also avoid this medication, as weakened kidney function can lead to severe muscle damage (rhabdomyolysis). It is advisable that women who are pregnant or may become pregnant, as well as those who are breastfeeding, do not take this medication due to potential harm to the fetus or infant. Patients with a history of allergies to this medication or its components should avoid its use as allergic reactions can be serious. Patients with gallbladder problems or a history of gallstones should also avoid this medication as it may worsen gallstone formation. Patients who have experienced photosensitivity reactions while taking other fibrates or ketoprofen should exercise caution in using this drug. This medication is not indicated for children as its safety and efficacy have not been sufficiently established. Patients with cholangitis or pancreatitis should avoid this medication, particularly in cases of acute hyperlipidemia-induced pancreatitis. This medication contains lactose; therefore, patients with lactose intolerance or specific genetic metabolic disorders should not take it. Patients with mildly impaired kidney function should reduce the dosage or prolong the dosing interval and regularly check kidney function. Patients with liver function abnormalities or a history of liver problems should undergo regular liver function tests, and if abnormalities are detected, the dosage should be adjusted or the medication discontinued. Patients taking anticoagulants should be cautious as there is an increased risk of bleeding, and blood tests should be performed frequently to monitor their condition. This medication may cause muscle-related side effects such as myalgia, muscle weakness, and increased creatine kinase levels, so any such symptoms should be reported to medical personnel immediately. Rash, itching, sensitivity to sunlight, and rarely hair loss may occur. Gastrointestinal side effects may include abdominal pain, nausea, vomiting, diarrhea, and in rare cases, pancreatitis, so caution is advised. Regular blood lipid tests should be conducted during the treatment period to verify therapeutic efficacy, and if no effect is observed, the medication should be discontinued. Elderly patients are at a higher risk of impaired liver and kidney functions and require special caution during treatment, as well as more frequent kidney function monitoring. When taking this medication alongside other drugs, especially statins, anticoagulants, or antihyperglycemics, there is an increased risk of adverse reactions due to drug interactions; therefore, consultation with a physician is essential. Due to potential harm to the fetus, this medication should not be taken during pregnancy, and breastfeeding should also be avoided while on this medication. There is no specific antidote for overdose, so adherence to prescribed dosages and the physician's instructions is crucial. This medication should be stored out of reach of children, and transferring it to another container should be avoided to prevent accidents and ensure the quality of the drug.
Hives, severe swelling (edema), anaphylaxis, angioedema, severe allergic reactions, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), acute hypersensitivity reactions, DRESS syndrome, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing, asthma attacks, pulmonary embolism, deep vein thrombosis, elevated blood pressure, acute pancreatitis, jaundice, hepatitis, cirrhosis, sudden
Increased serum aminotransferase levels, liver enlargement, cholestatic hepatitis, rash, itching, photosensitivity reactions, hair loss, malaise, hyperthermia, dizziness, headache, peripheral neuropathy, thromboembolism, increased creatine kinase, myalgia, muscle cramps, arthralgia, gastrointestinal disturbances (abdominal pain, nausea, vomiting, diarrhea, and abdominal bloating), hepatic dysfunction, decreased hemoglobin, leukopenia, eosinophilia, increased serum creatinine and urea, hypo
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container, protected from air and moisture, at a cool room temperature of 1 to 30 degrees Celsius. This will help maintain the drug's efficacy and prevent degradation.
White, elongated film-coated tablet
30 tablets/box [(10 tablets/blister x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFenofibrate 145mg
Tablet · Prescription medication
Abbott Korea Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Yu Yeong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.